Significance of FDA Approval of Impella for Cardiogenic Shock

April 7, 2016

Listen to Dr. William W. O’Neill, Medical Director for the Center for Structural Heart Disease at Henry Ford Hospital, discuss this new approval with Dr. Seth Bilazarian. (Tweet This)

To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: